IMMP

Immutep Limited American Depositary Shares (IMMP)

About Immutep Limited American Depositary Shares (IMMP)

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.

Details

Daily high

$2.17

Daily low

$2.03

Price at open

$2.11

52 Week High

$3.34

52 Week Low

$1.66

Market cap

295.5M

Dividend yield

0.00%

Volume

226,331

Avg. volume

157,812

P/E ratio

-8.75

Immutep Limited American Depositary Shares News